Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DDAVP | Ferring Pharmaceuticals | N-018938 RX | 1984-03-30 | 1 products, RLD, RS |
DDAVP | Ferring Pharmaceuticals | N-019955 RX | 1995-09-06 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
ddavp | New Drug Application | 2022-09-20 |
desmopressin acetate | ANDA | 2024-01-12 |
nocdurna | New Drug Application | 2021-08-06 |
Code | Description |
---|---|
J2597 | Injection, desmopressin acetate, per 1 mcg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Nocturia | D053158 | — | R35.1 | — | 7 | 16 | 2 | 9 | 32 |
Nocturnal enuresis | D053206 | — | N39.44 | — | — | 3 | 8 | 7 | 18 |
Hemophilia a | D006467 | EFO_0007267 | D66 | 1 | 1 | — | 2 | 3 | 7 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 1 | — | 2 | 1 | 5 |
Enuresis | D004775 | — | R32 | — | — | — | 2 | 1 | 3 |
Hypothermia | D007035 | HP_0002045 | T68 | — | — | — | 1 | 1 | 2 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | — | 1 | 1 | 2 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | — | 1 | 1 | 2 |
Postoperative hemorrhage | D019106 | — | — | — | — | — | 2 | — | 2 |
Cardiac surgical procedures | D006348 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyponatremia | D007010 | HP_0002902 | E87.1 | — | — | 1 | — | 2 | 3 |
Renal colic | D056844 | EFO_1001412 | N23 | — | — | 1 | — | 1 | 2 |
Neurogenic diabetes insipidus | D020790 | HP_0000863 | — | — | — | 1 | — | 1 | 2 |
Leptospirosis | D007922 | EFO_0007344 | A27 | — | 1 | 1 | — | — | 1 |
Inappropriate adh syndrome | D007177 | EFO_1000982 | E22.2 | — | 1 | 1 | — | — | 1 |
Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | — | — | 1 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Von willebrand diseases | D014842 | EFO_0003910 | D68.0 | — | 1 | — | — | 3 | 4 |
Stroke | D020521 | EFO_0000712 | I63.9 | 1 | 1 | — | — | — | 2 |
Cerebral hemorrhage | D002543 | — | — | — | 1 | — | — | — | 1 |
Thrombotic thrombocytopenic purpura | D011697 | — | M31.19 | — | 1 | — | — | — | 1 |
Type 2 von willebrand disease | D056728 | Orphanet_166081 | D68.02 | — | 1 | — | — | — | 1 |
Ecchymosis | D004438 | HP_0000978 | — | — | 1 | — | — | — | 1 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | 1 | — | — | — | 1 |
Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | — | 1 |
Dyspnea | D004417 | HP_0002094 | R06.0 | 1 | — | — | — | — | 1 |
Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | — | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | 1 | — | — | — | — | 1 |
Intracranial arteriosclerosis | D002537 | EFO_1000860 | I67.2 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes insipidus | D003919 | — | E23.2 | — | — | — | — | 2 | 2 |
Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 1 | 1 |
Hemodilution | D006438 | — | — | — | — | — | — | 1 | 1 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 1 | 1 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | — | — | — | 1 | 1 |
Blood platelet disorders | D001791 | — | — | — | — | — | — | 1 | 1 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Hypernatremia | D006955 | HP_0003228 | E87.0 | — | — | — | — | 1 | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | — | 1 | 1 |
Drug common name | Desmopressin |
INN | desmopressin |
Description | Desmopressin is a synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function. It has a role as a vasopressin receptor agonist, a renal agent and a diagnostic agent. |
Classification | Protein |
Drug class | vasoconstrictors (vasopressin derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |
PDB | — |
CAS-ID | 16679-58-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1429 |
ChEBI ID | 4450 |
PubChem CID | 5311065 |
DrugBank | DB00035 |
UNII ID | ENR1LLB0FP (ChemIDplus, GSRS) |